HOUSE_OVERSIGHT_025888.jpg
1.32 MB
Extraction Summary
4
People
4
Organizations
1
Locations
0
Events
1
Relationships
1
Quotes
Document Information
Type:
Email
File Size:
1.32 MB
Summary
This document is an email from Sultan Bin Sulayem to Jeffrey Epstein dated July 24, 2015. Sulayem forwards a Forbes article regarding the FDA approval of a new cholesterol-lowering drug called Praluent (by Regeneron Pharmaceuticals) and asks Epstein if he has heard of it. The document bears a House Oversight Bates stamp.
People (4)
| Name | Role | Context |
|---|---|---|
| Sultan Bin Sulayem | Sender |
Sent an email to Jeffrey Epstein inquiring about a cholesterol drug.
|
| Jeffrey Epstein | Recipient |
Received email at jeevacation@gmail.com.
|
| Matthew Herper | Journalist |
Author of the Forbes article forwarded in the email.
|
| Steven | Source |
Person quoted in the article (last name cut off).
|
Organizations (4)
| Name | Type | Context |
|---|---|---|
| Forbes |
Publisher of the article.
|
|
| FDA (Food and Drug Administration) |
Government body mentioned in the article headline.
|
|
| Regeneron Pharmaceuticals |
Biotech company mentioned in the article as the inventor of the drug.
|
|
| House Oversight Committee |
Source of the document (indicated by footer).
|
Locations (1)
| Location | Context |
|---|---|
|
Location of Regeneron Pharmaceuticals.
|
Relationships (1)
Direct email exchange sharing health/medical news.
Key Quotes (1)
"Have you heard of this colestrol"Source
HOUSE_OVERSIGHT_025888.jpg
Quote #1
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein document